CIDEB Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-24741
Key Product Details
Species Reactivity
Validated:
Human
Predicted:
Mouse (90%). Backed by our 100% Guarantee.
Applications
Immunocytochemistry/ Immunofluorescence
Label
Unconjugated
Antibody Source
Polyclonal Rabbit IgG
Concentration
Concentrations vary lot to lot. See vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
This antibody has been engineered to specifically recognize the recombinant protein CIDEB using the following amino acid sequence: TAVDSEDFFQLLEDDTCLMVLQSGQSWSPTRSGVLSYGLGRERPKHSKDIARFTFDVYKQNPRDLFGSLNV
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Scientific Data Images for CIDEB Antibody
Immunocytochemistry/Immunofluorescence: CIDEB Antibody [NBP3-24741]
Staining of human cell line Hep-G2 shows localization to the Golgi apparatus.Applications for CIDEB Antibody
Application
Recommended Usage
Immunocytochemistry/ Immunofluorescence
0.25-2 µg/ml
Application Notes
For ICC/IF, we recommend using a combination of PFA and Triton X-100. This will give you the optimal results for your experiments.
Formulation, Preparation, and Storage
Purification
Affinity purified
Formulation
PBS, pH 7.2, 40% glycerol
Preservative
0.02% Sodium Azide
Concentration
Concentrations vary lot to lot. See vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: CIDEB
Alternate Names
cell death-inducing DFFA-like effector bcell death activator CIDE-B
Gene Symbol
CIDEB
Additional CIDEB Products
Product Documents for CIDEB Antibody
Product Specific Notices for CIDEB Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...